Hidradenitis suppurativa trials in Norway

1 trial · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Enrolling by invitation
  A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa

  Where

  Oslo

  Age

  12 years and over

  People

  835 worldwide

  Run by

  MoonLake Immunotherapeutics AG

  See details and how to joinNCT07007637